Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial
CONTEXT It is not known whether patient outcomes are enhanced by effective pharmacist-patient interactions. OBJECTIVE To assess the effectiveness of a pharmaceutical care program for patients with asthma or chronic obstructive pulmonary disease (COPD). DESIGN, SETTING, AND PARTICIPANTS Randomized co...
Gespeichert in:
| Veröffentlicht in: | JAMA : the journal of the American Medical Association 2002-10, Vol.288 (13), p.1594-1602 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1602 |
|---|---|
| container_issue | 13 |
| container_start_page | 1594 |
| container_title | JAMA : the journal of the American Medical Association |
| container_volume | 288 |
| creator | Weinberger, Morris Murray, Michael D Marrero, David G Brewer, Nancy Lykens, Michael Harris, Lisa E Seshadri, Roopa Caffrey, Helena Roesner, J. Franklin Smith, Faye Newell, A. Jeffrey Collins, Joyce C McDonald, Clement J Tierney, William M |
| description | CONTEXT It is not known whether patient outcomes are enhanced by effective pharmacist-patient
interactions. OBJECTIVE To assess the effectiveness of a pharmaceutical care program for patients
with asthma or chronic obstructive pulmonary disease (COPD). DESIGN, SETTING, AND PARTICIPANTS Randomized controlled trial conducted at 36 community drugstores in
Indianapolis, Ind. We enrolled 1113 participants with active COPD or asthma
from July 1998 to December 1999. Outcomes were assessed in 947 (85.1%) participants
at 6 months and 898 (80.7%) at 12 months. INTERVENTIONS The pharmaceutical care program (n = 447) provided pharmacists with
recent patient-specific clinical data (peak expiratory flow rates [PEFRs],
emergency department [ED] visits, hospitalizations, and medication compliance),
training, customized patient educational materials, and resources to facilitate
program implementation. The PEFR monitoring control group (n = 363) received
a peak flow meter, instructions about its use, and monthly calls to elicit
PEFRs. However, PEFR data were not provided to the pharmacist. Patients in
the usual care group (n = 303) received neither peak flow meters nor instructions
in their use; during monthly telephone interviews, PEFR rates were not elicited.
Pharmacists in both control groups had a training session but received no
components of the pharmaceutical care intervention. MAIN OUTCOME MEASURES Peak expiratory flow rates, breathing-related ED or hospital visits,
health-related quality of life (HRQOL), medication compliance, and patient
satisfaction. RESULTS At 12 months, patients receiving pharmaceutical care had significantly
higher peak flow rates than the usual care group (P =
.02) but not than PEFR monitoring controls (P = .28).
There were no significant between-group differences in medication compliance
or HRQOL. Asthma patients receiving pharmaceutical care had significantly
more breathing-related ED or hospital visits than the usual care group (odds
ratio, 2.16; 95% confidence interval, 1.76-2.63; P |
| doi_str_mv | 10.1001/jama.288.13.1594 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72135893</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>195343</ama_id><sourcerecordid>72135893</sourcerecordid><originalsourceid>FETCH-LOGICAL-a282t-34adf39bae7b0d6fc9e1d02a8426f7ae44a9d2b67a6924454d6764943a7ed9083</originalsourceid><addsrcrecordid>eNpd0d1LHDEQAPBQlHo9-25fShDatz3ztZvEt-N6rYLgcSh9XOY2E8yxH5rsVfSvb9ATwbxMYH4zDDOEnHA244zxsy10MBPGzLic8dKqT2TCS2kKWVpzQCaMWVNoZdQR-ZLSluXHpf5MjriQJeOWTch26T02Y_iHPaZEB09XdxA7aEIa6QIiUj9EuoIxYD8m-jeMd3SN8FJB5yE-wlOiv0JCSHhO53QNvRu68IyOLoZ-jEPb5u9NDNAek0MPbcKv-zglt7-XN4uL4ur6z-ViflWAMGIspALnpd0A6g1zlW8scscEGCUqrwGVAuvEptJQWaFUqVylK2WVBI3OMiOn5Odr3_s4POwwjXUXUoNtCz0Ou1RrwWVprMzw9APcDrvY59lqwbORgquMvu_RbtOhq-9j6CA-1W8rzODHHkBqoPUR-ry8dyet5kqJ7L69unyz96wtpZLyP62TiB4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211353214</pqid></control><display><type>article</type><title>Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Weinberger, Morris ; Murray, Michael D ; Marrero, David G ; Brewer, Nancy ; Lykens, Michael ; Harris, Lisa E ; Seshadri, Roopa ; Caffrey, Helena ; Roesner, J. Franklin ; Smith, Faye ; Newell, A. Jeffrey ; Collins, Joyce C ; McDonald, Clement J ; Tierney, William M</creator><creatorcontrib>Weinberger, Morris ; Murray, Michael D ; Marrero, David G ; Brewer, Nancy ; Lykens, Michael ; Harris, Lisa E ; Seshadri, Roopa ; Caffrey, Helena ; Roesner, J. Franklin ; Smith, Faye ; Newell, A. Jeffrey ; Collins, Joyce C ; McDonald, Clement J ; Tierney, William M</creatorcontrib><description>CONTEXT It is not known whether patient outcomes are enhanced by effective pharmacist-patient
interactions. OBJECTIVE To assess the effectiveness of a pharmaceutical care program for patients
with asthma or chronic obstructive pulmonary disease (COPD). DESIGN, SETTING, AND PARTICIPANTS Randomized controlled trial conducted at 36 community drugstores in
Indianapolis, Ind. We enrolled 1113 participants with active COPD or asthma
from July 1998 to December 1999. Outcomes were assessed in 947 (85.1%) participants
at 6 months and 898 (80.7%) at 12 months. INTERVENTIONS The pharmaceutical care program (n = 447) provided pharmacists with
recent patient-specific clinical data (peak expiratory flow rates [PEFRs],
emergency department [ED] visits, hospitalizations, and medication compliance),
training, customized patient educational materials, and resources to facilitate
program implementation. The PEFR monitoring control group (n = 363) received
a peak flow meter, instructions about its use, and monthly calls to elicit
PEFRs. However, PEFR data were not provided to the pharmacist. Patients in
the usual care group (n = 303) received neither peak flow meters nor instructions
in their use; during monthly telephone interviews, PEFR rates were not elicited.
Pharmacists in both control groups had a training session but received no
components of the pharmaceutical care intervention. MAIN OUTCOME MEASURES Peak expiratory flow rates, breathing-related ED or hospital visits,
health-related quality of life (HRQOL), medication compliance, and patient
satisfaction. RESULTS At 12 months, patients receiving pharmaceutical care had significantly
higher peak flow rates than the usual care group (P =
.02) but not than PEFR monitoring controls (P = .28).
There were no significant between-group differences in medication compliance
or HRQOL. Asthma patients receiving pharmaceutical care had significantly
more breathing-related ED or hospital visits than the usual care group (odds
ratio, 2.16; 95% confidence interval, 1.76-2.63; P<.001).
Patients receiving pharmaceutical care were more satisfied with their pharmacist
than the usual care group (P = .03) and the PEFR
monitoring group (P = .001) and were more satisfied
with their health care than the usual care group at 6 months only (P = .01). Despite ample opportunities to implement the program, pharmacists
accessed patient-specific data only about half of the time and documented
actions about half of the time that records were accessed. CONCLUSIONS This pharmaceutical care program increased patients' PEFRs compared
with usual care but provided little benefit compared with peak flow monitoring
alone. Pharmaceutical care increased patient satisfaction but also increased
the amount of breathing-related medical care sought.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.288.13.1594</identifier><identifier>PMID: 12350190</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>Chicago, IL: American Medical Association</publisher><subject>Adult ; Ambulatory Care Facilities ; Asthma - therapy ; Biological and medical sciences ; Clinical outcomes ; Clinical trials ; Emergencies ; Female ; Humans ; Indiana ; Investigative techniques, diagnostic techniques (general aspects) ; Male ; Medical sciences ; Middle Aged ; Outcome Assessment (Health Care) ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Patient Compliance ; Patient education ; Patient Satisfaction ; Peak Expiratory Flow Rate ; Pharmacies ; Pharmacists ; Pulmonary Disease, Chronic Obstructive - therapy ; Respiratory diseases ; Respiratory system ; Sickness Impact Profile</subject><ispartof>JAMA : the journal of the American Medical Association, 2002-10, Vol.288 (13), p.1594-1602</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright American Medical Association Oct 2, 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.288.13.1594$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.288.13.1594$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,776,780,3327,27901,27902,76231,76234</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13971442$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12350190$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weinberger, Morris</creatorcontrib><creatorcontrib>Murray, Michael D</creatorcontrib><creatorcontrib>Marrero, David G</creatorcontrib><creatorcontrib>Brewer, Nancy</creatorcontrib><creatorcontrib>Lykens, Michael</creatorcontrib><creatorcontrib>Harris, Lisa E</creatorcontrib><creatorcontrib>Seshadri, Roopa</creatorcontrib><creatorcontrib>Caffrey, Helena</creatorcontrib><creatorcontrib>Roesner, J. Franklin</creatorcontrib><creatorcontrib>Smith, Faye</creatorcontrib><creatorcontrib>Newell, A. Jeffrey</creatorcontrib><creatorcontrib>Collins, Joyce C</creatorcontrib><creatorcontrib>McDonald, Clement J</creatorcontrib><creatorcontrib>Tierney, William M</creatorcontrib><title>Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>CONTEXT It is not known whether patient outcomes are enhanced by effective pharmacist-patient
interactions. OBJECTIVE To assess the effectiveness of a pharmaceutical care program for patients
with asthma or chronic obstructive pulmonary disease (COPD). DESIGN, SETTING, AND PARTICIPANTS Randomized controlled trial conducted at 36 community drugstores in
Indianapolis, Ind. We enrolled 1113 participants with active COPD or asthma
from July 1998 to December 1999. Outcomes were assessed in 947 (85.1%) participants
at 6 months and 898 (80.7%) at 12 months. INTERVENTIONS The pharmaceutical care program (n = 447) provided pharmacists with
recent patient-specific clinical data (peak expiratory flow rates [PEFRs],
emergency department [ED] visits, hospitalizations, and medication compliance),
training, customized patient educational materials, and resources to facilitate
program implementation. The PEFR monitoring control group (n = 363) received
a peak flow meter, instructions about its use, and monthly calls to elicit
PEFRs. However, PEFR data were not provided to the pharmacist. Patients in
the usual care group (n = 303) received neither peak flow meters nor instructions
in their use; during monthly telephone interviews, PEFR rates were not elicited.
Pharmacists in both control groups had a training session but received no
components of the pharmaceutical care intervention. MAIN OUTCOME MEASURES Peak expiratory flow rates, breathing-related ED or hospital visits,
health-related quality of life (HRQOL), medication compliance, and patient
satisfaction. RESULTS At 12 months, patients receiving pharmaceutical care had significantly
higher peak flow rates than the usual care group (P =
.02) but not than PEFR monitoring controls (P = .28).
There were no significant between-group differences in medication compliance
or HRQOL. Asthma patients receiving pharmaceutical care had significantly
more breathing-related ED or hospital visits than the usual care group (odds
ratio, 2.16; 95% confidence interval, 1.76-2.63; P<.001).
Patients receiving pharmaceutical care were more satisfied with their pharmacist
than the usual care group (P = .03) and the PEFR
monitoring group (P = .001) and were more satisfied
with their health care than the usual care group at 6 months only (P = .01). Despite ample opportunities to implement the program, pharmacists
accessed patient-specific data only about half of the time and documented
actions about half of the time that records were accessed. CONCLUSIONS This pharmaceutical care program increased patients' PEFRs compared
with usual care but provided little benefit compared with peak flow monitoring
alone. Pharmaceutical care increased patient satisfaction but also increased
the amount of breathing-related medical care sought.</description><subject>Adult</subject><subject>Ambulatory Care Facilities</subject><subject>Asthma - therapy</subject><subject>Biological and medical sciences</subject><subject>Clinical outcomes</subject><subject>Clinical trials</subject><subject>Emergencies</subject><subject>Female</subject><subject>Humans</subject><subject>Indiana</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Outcome Assessment (Health Care)</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Patient Compliance</subject><subject>Patient education</subject><subject>Patient Satisfaction</subject><subject>Peak Expiratory Flow Rate</subject><subject>Pharmacies</subject><subject>Pharmacists</subject><subject>Pulmonary Disease, Chronic Obstructive - therapy</subject><subject>Respiratory diseases</subject><subject>Respiratory system</subject><subject>Sickness Impact Profile</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpd0d1LHDEQAPBQlHo9-25fShDatz3ztZvEt-N6rYLgcSh9XOY2E8yxH5rsVfSvb9ATwbxMYH4zDDOEnHA244zxsy10MBPGzLic8dKqT2TCS2kKWVpzQCaMWVNoZdQR-ZLSluXHpf5MjriQJeOWTch26T02Y_iHPaZEB09XdxA7aEIa6QIiUj9EuoIxYD8m-jeMd3SN8FJB5yE-wlOiv0JCSHhO53QNvRu68IyOLoZ-jEPb5u9NDNAek0MPbcKv-zglt7-XN4uL4ur6z-ViflWAMGIspALnpd0A6g1zlW8scscEGCUqrwGVAuvEptJQWaFUqVylK2WVBI3OMiOn5Odr3_s4POwwjXUXUoNtCz0Ou1RrwWVprMzw9APcDrvY59lqwbORgquMvu_RbtOhq-9j6CA-1W8rzODHHkBqoPUR-ry8dyet5kqJ7L69unyz96wtpZLyP62TiB4</recordid><startdate>20021002</startdate><enddate>20021002</enddate><creator>Weinberger, Morris</creator><creator>Murray, Michael D</creator><creator>Marrero, David G</creator><creator>Brewer, Nancy</creator><creator>Lykens, Michael</creator><creator>Harris, Lisa E</creator><creator>Seshadri, Roopa</creator><creator>Caffrey, Helena</creator><creator>Roesner, J. Franklin</creator><creator>Smith, Faye</creator><creator>Newell, A. Jeffrey</creator><creator>Collins, Joyce C</creator><creator>McDonald, Clement J</creator><creator>Tierney, William M</creator><general>American Medical Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20021002</creationdate><title>Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial</title><author>Weinberger, Morris ; Murray, Michael D ; Marrero, David G ; Brewer, Nancy ; Lykens, Michael ; Harris, Lisa E ; Seshadri, Roopa ; Caffrey, Helena ; Roesner, J. Franklin ; Smith, Faye ; Newell, A. Jeffrey ; Collins, Joyce C ; McDonald, Clement J ; Tierney, William M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a282t-34adf39bae7b0d6fc9e1d02a8426f7ae44a9d2b67a6924454d6764943a7ed9083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Ambulatory Care Facilities</topic><topic>Asthma - therapy</topic><topic>Biological and medical sciences</topic><topic>Clinical outcomes</topic><topic>Clinical trials</topic><topic>Emergencies</topic><topic>Female</topic><topic>Humans</topic><topic>Indiana</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Outcome Assessment (Health Care)</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Patient Compliance</topic><topic>Patient education</topic><topic>Patient Satisfaction</topic><topic>Peak Expiratory Flow Rate</topic><topic>Pharmacies</topic><topic>Pharmacists</topic><topic>Pulmonary Disease, Chronic Obstructive - therapy</topic><topic>Respiratory diseases</topic><topic>Respiratory system</topic><topic>Sickness Impact Profile</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weinberger, Morris</creatorcontrib><creatorcontrib>Murray, Michael D</creatorcontrib><creatorcontrib>Marrero, David G</creatorcontrib><creatorcontrib>Brewer, Nancy</creatorcontrib><creatorcontrib>Lykens, Michael</creatorcontrib><creatorcontrib>Harris, Lisa E</creatorcontrib><creatorcontrib>Seshadri, Roopa</creatorcontrib><creatorcontrib>Caffrey, Helena</creatorcontrib><creatorcontrib>Roesner, J. Franklin</creatorcontrib><creatorcontrib>Smith, Faye</creatorcontrib><creatorcontrib>Newell, A. Jeffrey</creatorcontrib><creatorcontrib>Collins, Joyce C</creatorcontrib><creatorcontrib>McDonald, Clement J</creatorcontrib><creatorcontrib>Tierney, William M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weinberger, Morris</au><au>Murray, Michael D</au><au>Marrero, David G</au><au>Brewer, Nancy</au><au>Lykens, Michael</au><au>Harris, Lisa E</au><au>Seshadri, Roopa</au><au>Caffrey, Helena</au><au>Roesner, J. Franklin</au><au>Smith, Faye</au><au>Newell, A. Jeffrey</au><au>Collins, Joyce C</au><au>McDonald, Clement J</au><au>Tierney, William M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2002-10-02</date><risdate>2002</risdate><volume>288</volume><issue>13</issue><spage>1594</spage><epage>1602</epage><pages>1594-1602</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><abstract>CONTEXT It is not known whether patient outcomes are enhanced by effective pharmacist-patient
interactions. OBJECTIVE To assess the effectiveness of a pharmaceutical care program for patients
with asthma or chronic obstructive pulmonary disease (COPD). DESIGN, SETTING, AND PARTICIPANTS Randomized controlled trial conducted at 36 community drugstores in
Indianapolis, Ind. We enrolled 1113 participants with active COPD or asthma
from July 1998 to December 1999. Outcomes were assessed in 947 (85.1%) participants
at 6 months and 898 (80.7%) at 12 months. INTERVENTIONS The pharmaceutical care program (n = 447) provided pharmacists with
recent patient-specific clinical data (peak expiratory flow rates [PEFRs],
emergency department [ED] visits, hospitalizations, and medication compliance),
training, customized patient educational materials, and resources to facilitate
program implementation. The PEFR monitoring control group (n = 363) received
a peak flow meter, instructions about its use, and monthly calls to elicit
PEFRs. However, PEFR data were not provided to the pharmacist. Patients in
the usual care group (n = 303) received neither peak flow meters nor instructions
in their use; during monthly telephone interviews, PEFR rates were not elicited.
Pharmacists in both control groups had a training session but received no
components of the pharmaceutical care intervention. MAIN OUTCOME MEASURES Peak expiratory flow rates, breathing-related ED or hospital visits,
health-related quality of life (HRQOL), medication compliance, and patient
satisfaction. RESULTS At 12 months, patients receiving pharmaceutical care had significantly
higher peak flow rates than the usual care group (P =
.02) but not than PEFR monitoring controls (P = .28).
There were no significant between-group differences in medication compliance
or HRQOL. Asthma patients receiving pharmaceutical care had significantly
more breathing-related ED or hospital visits than the usual care group (odds
ratio, 2.16; 95% confidence interval, 1.76-2.63; P<.001).
Patients receiving pharmaceutical care were more satisfied with their pharmacist
than the usual care group (P = .03) and the PEFR
monitoring group (P = .001) and were more satisfied
with their health care than the usual care group at 6 months only (P = .01). Despite ample opportunities to implement the program, pharmacists
accessed patient-specific data only about half of the time and documented
actions about half of the time that records were accessed. CONCLUSIONS This pharmaceutical care program increased patients' PEFRs compared
with usual care but provided little benefit compared with peak flow monitoring
alone. Pharmaceutical care increased patient satisfaction but also increased
the amount of breathing-related medical care sought.</abstract><cop>Chicago, IL</cop><pub>American Medical Association</pub><pmid>12350190</pmid><doi>10.1001/jama.288.13.1594</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0098-7484 |
| ispartof | JAMA : the journal of the American Medical Association, 2002-10, Vol.288 (13), p.1594-1602 |
| issn | 0098-7484 1538-3598 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72135893 |
| source | MEDLINE; American Medical Association Journals |
| subjects | Adult Ambulatory Care Facilities Asthma - therapy Biological and medical sciences Clinical outcomes Clinical trials Emergencies Female Humans Indiana Investigative techniques, diagnostic techniques (general aspects) Male Medical sciences Middle Aged Outcome Assessment (Health Care) Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques Patient Compliance Patient education Patient Satisfaction Peak Expiratory Flow Rate Pharmacies Pharmacists Pulmonary Disease, Chronic Obstructive - therapy Respiratory diseases Respiratory system Sickness Impact Profile |
| title | Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A58%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20Pharmacist%20Care%20for%20Patients%20With%20Reactive%20Airways%20Disease:%20A%20Randomized%20Controlled%20Trial&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Weinberger,%20Morris&rft.date=2002-10-02&rft.volume=288&rft.issue=13&rft.spage=1594&rft.epage=1602&rft.pages=1594-1602&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/jama.288.13.1594&rft_dat=%3Cproquest_pubme%3E72135893%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211353214&rft_id=info:pmid/12350190&rft_ama_id=195343&rfr_iscdi=true |